Abstract | OBJECTIVE: To investigate whether artificial tears and cold compress alone or in combination provide a treatment benefit and whether they were as effective as or could enhance topical antiallergic medication. DESIGN: Randomized, masked clinical trial. PARTICIPANTS: Eighteen subjects (mean age, 29.5±11.0 years) allergic to grass pollen. INTERVENTION: Controlled exposure to grass pollen using an environmental chamber to stimulate an ocular allergic reaction followed by application of artificial tears (ATs), 5 minutes of cold compress (CC), ATs combined with CC, or no treatment applied at each separate visit in random order. A subset of 11 subjects also had epinastine hydrochloride (EH) applied alone and combined with CC in random order or instillation of a volume-matched saline control. MAIN OUTCOME MEASURES: Bulbar conjunctival hyperemia, ocular surface temperature, and ocular symptoms repeated before and every 10 minutes after treatment for 1 hour. RESULTS: Bulbar conjunctival hyperemia and ocular symptoms decreased and temperature recovered to baseline faster with nonpharmaceutical treatments compared with no treatment (P <0.05). Artificial tears combined with CC reduced hyperemia more than other treatments (P <0.05). The treatment effect of EH was enhanced by combining it with a CC (P <0.001). Cold compress combined with ATs or EH lowered the antigen-raised ocular surface temperature to less than the pre-exposure baseline. Artificial tear instillation alone or CC combined with ATs or EH significantly reduced the temperature (P <0.05). Cold compress combined with ATs or EH had a similar cooling effect (P >0.05). At all measurement intervals, symptoms were reduced for both EH and EH combined with CC than CC or ATs alone or in combination (P <0.014). CONCLUSIONS: After controlled exposure to grass pollen, CC and AT treatment showed a therapeutic effect on the signs and symptoms of allergic conjunctivitis. A CC enhanced the use of EH alone and was the only treatment to reduce symptoms to baseline within 1 hour of antigenic challenge. Signs of allergic conjunctivitis generally were reduced most by a combination of a CC in combination with ATs or EH.
|
Authors | Paramdeep S Bilkhu, James S Wolffsohn, Shehzad A Naroo, Louise Robertson, Roy Kennedy |
Journal | Ophthalmology
(Ophthalmology)
Vol. 121
Issue 1
Pg. 72-78
(Jan 2014)
ISSN: 1549-4713 [Electronic] United States |
PMID | 24070810
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Allergens
- Dibenzazepines
- Histamine H1 Antagonists
- Imidazoles
- Ophthalmic Solutions
- epinastine
|
Topics |
- Acute Disease
- Adult
- Aged
- Allergens
(adverse effects)
- Combined Modality Therapy
- Conjunctiva
(blood supply)
- Conjunctivitis, Allergic
(diagnosis, etiology, therapy)
- Cryotherapy
- Dibenzazepines
(administration & dosage)
- Double-Blind Method
- Female
- Histamine H1 Antagonists
(administration & dosage)
- Humans
- Hyperemia
(chemically induced, drug therapy)
- Imidazoles
(administration & dosage)
- Male
- Middle Aged
- Ophthalmic Solutions
(administration & dosage)
- Pollen
(adverse effects)
- Seasons
- Skin Tests
- Treatment Outcome
- Young Adult
|